JPMorgan Chase & Co’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Sell |
760,415
-44,749
| -6% | -$122K | ﹤0.01% | 3319 |
|
|
2025
Q1 | $1.35M | Sell |
805,164
-1,471
| -0.2% | -$2.47K | ﹤0.01% | 3490 |
|
|
2024
Q4 | $1.31M | Sell |
806,635
-110,538
| -12% | -$180K | ﹤0.01% | 3638 |
|
|
2024
Q3 | $3.82M | Sell |
917,173
-34,391
| -4% | -$143K | ﹤0.01% | 2803 |
|
|
2024
Q2 | $5.2M | Sell |
951,564
-153,923
| -14% | -$840K | ﹤0.01% | 2505 |
|
|
2024
Q1 | $11.1M | Sell |
1,105,487
-85,147
| -7% | -$851K | ﹤0.01% | 2056 |
|
|
2023
Q4 | $4.86M | Buy |
1,190,634
+13,302
| +1% | +$54.3K | ﹤0.01% | 2579 |
|
|
2023
Q3 | $4.56M | Sell |
1,177,332
-60,466
| -5% | -$234K | ﹤0.01% | 2486 |
|
|
2023
Q2 | $7.38M | Sell |
1,237,798
-1,204,505
| -49% | -$7.18M | ﹤0.01% | 2251 |
|
|
2023
Q1 | $7.99M | Buy |
2,442,303
+66,301
| +3% | +$217K | ﹤0.01% | 2162 |
|
|
2022
Q4 | $9.39M | Sell |
2,376,002
-3,710
| -0.2% | -$14.7K | ﹤0.01% | 1969 |
|
|
2022
Q3 | $14.3M | Sell |
2,379,712
-115,602
| -5% | -$694K | ﹤0.01% | 1626 |
|
|
2022
Q2 | $16M | Buy |
2,495,314
+9,535
| +0.4% | +$61.3K | ﹤0.01% | 1581 |
|
|
2022
Q1 | $20.5M | Buy |
2,485,779
+469,673
| +23% | +$3.88M | ﹤0.01% | 1531 |
|
|
2021
Q4 | $31.2M | Buy |
2,016,106
+390,684
| +24% | +$6.05M | ﹤0.01% | 1300 |
|
|
2021
Q3 | $36.6M | Buy |
1,625,422
+370,123
| +29% | +$8.34M | ﹤0.01% | 1212 |
|
|
2021
Q2 | $24.7M | Sell |
1,255,299
-269,713
| -18% | -$5.3M | ﹤0.01% | 1481 |
|
|
2021
Q1 | $51M | Buy |
+1,525,012
| New | +$51M | 0.01% | 1068 |
|